history of glp-1 agonists Evolution GLP‐1 Receptor for Diabetes Treatment Evolution of GLP-1 Agonists in

These targeted improvements often translate into a better quality of life, making peptide therapy a valuable option for those seeking noticeable and meaningful results in their wellness journey

Body Protection Compound 157, or BPC-157, is a synthetic pentadecapeptide

The association between hyperuricaemia and the Trp64Arg polymorphism of the -3 adrenergic receptor

While diet and exercise is often recommended for weight loss, during your weight loss journey, a very common problem that people face is weight-loss plateau

Proc Natl Acad Sci USA 1991;88:36336

showed that Exos from HO-1/BMSCs containing miR-29a-3p mitigated hepatic IRI by negatively regulating IREB2 protein levels, lowering intracellular Fe 2+ concentrations, increasing lipid ROS levels, and inhibiting ferroptosis [169] (Table 1)